An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor tyrosine-kinase inhibitor therapy

Autor:	Grünwald V., Karakiewicz P. . I, Bavbek S. . E, Miller K., Machiels J. P., Lee S. H., Larkin J., Bono P., Rha S. Y., Castellano D., Blank C. U., Knox J. J., Hawkins R., Anak O., Rosamilia M., Booth J., Pirotta N., Bodrogi I., REACT Study Group, included, DE PLACIDO, SABINO
Přispěvatelé:	Grünwald, V., Karakiewicz, P. . I., Bavbek, S. . E., Miller, K., Machiels, J. P., Lee, S. H., Larkin, J., Bono, P., Rha, S. Y., Castellano, D., Blank, C. U., Knox, J. J., Hawkins, R., Anak, O., Rosamilia, M., Booth, J., Pirotta, N., Bodrogi, I., REACT Study, Group, Included, DE PLACIDO, Sabino
Rok vydání:	2012
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______3730::58f28b07ad8c21b2a6368e3939d307fa http://hdl.handle.net/11588/464339 Zobrazit plný text záznamu